Literature DB >> 27887796

Vaccine strategies: Optimising outcomes.

Karin Hardt1, Paolo Bonanni2, Susan King3, Jose Ignacio Santos4, Mostafa El-Hodhod5, Gregory D Zimet6, Scott Preiss7.   

Abstract

Successful immunisation programmes generally result from high vaccine effectiveness and adequate uptake of vaccines. In the development of new vaccination strategies, the structure and strength of the local healthcare system is a key consideration. In high income countries, existing infrastructures are usually used, while in less developed countries, the capacity for introducing new vaccines may need to be strengthened, particularly for vaccines administered beyond early childhood, such as the measles or human papillomavirus (HPV) vaccine. Reliable immunisation service funding is another important factor and low income countries often need external supplementary sources of finance. Many regions also obtain support in generating an evidence base for vaccination via initiatives created by organisations including World Health Organization (WHO), the Pan American Health Organization (PAHO), the Agence de Médecine Préventive and the Sabin Vaccine Institute. Strong monitoring and surveillance mechanisms are also required. An example is the efficient and low-cost approaches for measuring the impact of the hepatitis B control initiative and evaluating achievement of goals that have been established in the WHO Western Pacific region. A review of implementation strategies reveals differing degrees of success. For example, in the Americas, PAHO advanced a measles-mumps-rubella vaccine strategy, targeting different population groups in mass, catch-up and follow-up vaccination campaigns. This has had much success but coverage data from some parts of the region suggest that children are still not receiving all appropriate vaccines, highlighting problems with local service infrastructures. Stark differences in coverage levels are also observed among high income countries, as is the case with HPV vaccine implementation in the USA versus the UK and Australia, reflecting differences in delivery settings. Experience and research have shown which vaccine strategies work well and the factors that encourage success, which often include strong support from government and healthcare organisations, as well as tailored, culturally-appropriate local approaches to optimise outcomes. Copyright Â
© 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Coverage; Implementation; National immunisation programme; Planning; Strategy; Vaccination

Mesh:

Substances:

Year:  2016        PMID: 27887796     DOI: 10.1016/j.vaccine.2016.10.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

Review 1.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

2.  A Vaccination Simulator for COVID-19: Effective and Sterilizing Immunization Cases.

Authors:  Aknur Karabay; Askat Kuzdeuov; Shyryn Ospanova; Michael Lewis; Huseyin Atakan Varol
Journal:  IEEE J Biomed Health Inform       Date:  2021-12-06       Impact factor: 5.772

3.  Factors Influencing COVID-19 Vaccine Acceptance in the Workplace: Results From a Rapid Survey at 2 Corporations in Los Angeles County, California, 2021.

Authors:  Lori Fischbach; Rachel Civen; Homer Boyd; David M Flores; Jennifer Cloud; Lisa V Smith; Jan King; Frank Alvarez; Tony Kuo
Journal:  Public Health Rep       Date:  2022-08-25       Impact factor: 3.117

4.  Determinants of COVID-19 Vaccine Acceptance and Uptake in a Transborder Population at the Mexico-Guatemala Border, September-November 2021.

Authors:  Ietza Bojorquez; René Leyva-Flores; César Rodríguez-Chávez; Carlos Hernández-Campos; Marcel Arévalo; Ricardo Cortés-Alcalá; Georgina Rodríguez-Elizondo; Sandra Ward; Rebecca Merrill; Alfonso Rodriguez-Lainz; Dianne Escotto; Nirma Bustamante
Journal:  Int J Environ Res Public Health       Date:  2022-06-06       Impact factor: 4.614

5.  Intention to accept pertussis vaccination among Chinese people older than age 5.

Authors:  Xuewen Tang; Tingting Tang; Rui Yan; Yang Zhou; Xuan Deng; Hanqing He
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

6.  Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis.

Authors:  Thinley Dorji; Tanawin Nopsopon; Saran Tenzin Tamang; Krit Pongpirul
Journal:  EClinicalMedicine       Date:  2021-04-17

7.  Approaches to Vaccination Among Populations in Areas of Conflict.

Authors:  Chimeremma Nnadi; Andrew Etsano; Belinda Uba; Chima Ohuabunwo; Musa Melton; Gatei Wa Nganda; Lisa Esapa; Omotayo Bolu; Frank Mahoney; John Vertefeuille; Eric Wiesen; Elias Durry
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Do Primary Care Physicians Contribute to the Immunization Status of Their Adult Patients? A Story of Patients' Overconfidence Coupled With Physicians' Passivity.

Authors:  Thibaut Papis; Christine Clavien
Journal:  Front Med (Lausanne)       Date:  2021-06-17

9.  Is there an association between the use of complementary medicine and vaccine uptake: results of a pilot study.

Authors:  Jane E Frawley; Erica McIntyre; Jon Wardle; Debra Jackson
Journal:  BMC Res Notes       Date:  2018-04-02

10.  MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice.

Authors:  Hye-Jung Kim; Hye Won Kwak; Kyung Won Kang; Yoo-Jin Bang; Yu-Sun Lee; Hyeong-Jun Park; Jae-Yong Kim; Hyo-Jung Park; Kyung-Ah Hwang; Sang-Myeong Lee; Jae-Hwan Nam
Journal:  Pharmaceutics       Date:  2020-05-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.